Partial or full A1agonists-N-6 heterocyclic 5′-thio substituted adenosine derivatives
US6605597B1 · kind B1 · utility
59Cited by
5References
13Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Dec 3, 1999 |
| Grant date | Aug 12, 2003 |
| Priority date | — |
| Expiry date | Dec 3, 2019 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P43/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
N6 heterocyclic 5′ modified adenosine derivatives that are adenosine A1 receptor partial or full agonists, and as such, are useful for modifying cardiac activity, modifying adipocyte function, treating central nervous system disorders, and treating diabetic disorders and obesity in mammals, and especially in humans.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.